13F filer · CIK 1697748 ↗
ARK Invest
You are looking at Q3 2024. See the latest, Q2 2026 →
Reported value
$10.93B
−3.0% on the quarter before
Positions
194
12 new · 8 sold out
Top 10
49.5%
of the value
Est. gain
+$744.9M
on stocks held all quarter
Est. return
+7.7%
on those stocks since Q2 2024
Positions as of Sep 30, 2024, from ARK Invest's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q2 2024. Striped tiles are options.
Largest buys
Since Q2 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Tempus AI~$105.0MAdded · 0.2% → 1.2%+1,855,459 shares
- AMD~$90.0MAdded · 0.3% → 1.2%+548,515 shares
- Amazon~$46.5MAdded · 0.2% → 0.6%+249,633 shares
- Natera Inc~$34.6MAdded · 0.4% → 0.8%+272,361 shares
- 10x Genomics Inc~$32.4MAdded · 1.6% → 2.2%+1,436,582 shares
- Recursion Pharmaceuticals Inc~$30.5MAdded · 1.9% → 2.0%+4,626,268 shares
- Guardant Health Inc~$24.3MAdded · 0.1% → 0.3%+1,059,104 shares
- Intellia Therapeutics Inc~$13.6MAdded · 2.3% → 2.3%+659,651 shares
- Gitlab Inc~$13.4MNew · 0.0% → 0.1%+260,679 shares
- Reddit Inc~$12.7MAdded · 0.1% → 0.2%+192,785 shares
Largest sells
Since Q2 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Tesla~$189.8MCut · 9.3% → 11.0%−725,614 shares
- Zoom~$175.8MCut · 1.3% → 0.0%−2,520,834 shares
- UiPath~$112.6MCut · 3.3% → 2.5%−8,797,635 shares
- Block~$111.9MCut · 4.7% → 4.1%−1,667,032 shares
- Roku Inc~$111.6MCut · 6.8% → 7.7%−1,494,385 shares
- Unity Software Inc~$104.9MCut · 1.6% → 1.4%−4,639,335 shares
- Caredx Inc~$84.7MCut · 0.8% → 0.9%−2,713,754 shares
- Palantir~$74.6MCut · 2.9% → 3.7%−2,005,325 shares
- Roblox~$66.3MCut · 4.4% → 4.8%−1,497,419 shares
- Veracyte Inc~$64.3MCut · 1.3% → 1.5%−1,888,552 shares
Holdings
As of Sep 30, 2024. Changes are in shares against Jun 30, 2024, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TeslaCommon Stock · shares −14% · price +32.2% | 11.0% | $1.20B | +$292.5M | ||||||||
| Roku IncCommon Stock · shares −12% · price +24.6% | 7.7% | $837.8M | +$165.3M | ||||||||
| CoinbaseCommon Stock · shares −8.9% · price −19.8% | 5.3% | $577.5M | −$142.8M | ||||||||
| RobloxCommon Stock · shares −11% · price +18.9% | 4.8% | $524.1M | +$83.5M | ||||||||
| BlockCommon Stock · shares −20% · price +4.1% | 4.1% | $444.8M | +$17.5M | ||||||||
| RobinhoodCommon Stock · shares −6.2% · price +3.1% | 3.8% | $421.0M | +$12.8M | ||||||||
| PalantirCommon Stock · shares −15% · price +46.9% | 3.7% | $409.9M | +$130.8M | ||||||||
| Shopify IncCommon Stock · shares −6.0% · price +21.3% | 3.4% | $374.3M | +$65.8M | ||||||||
| Crispr Therapeutics AgCommon Stock · shares −3.6% · price −13.0% | 3.2% | $352.3M | −$52.7M | ||||||||
| UiPathCommon Stock · shares −30% · price +0.9% | 2.5% | $268.2M | +$2.5M | ||||||||
| Intellia Therapeutics IncCommon Stock · shares +5.7% · price −8.2% | 2.3% | $251.8M | −$21.2M | ||||||||
| 10x Genomics IncCommon Stock · shares +15% · price +16.1% | 2.2% | $242.7M | +$29.2M | ||||||||
| Twist Bioscience CorpCommon Stock · shares −13% · price −8.3% | 2.2% | $242.1M | −$22.0M | ||||||||
| Draftkings IncCommon Stock · shares −2.6% · price +2.7% | 2.2% | $236.2M | +$6.2M | ||||||||
| MetaCommon Stock · shares −8.2% · price +13.5% | 2.1% | $227.8M | +$27.1M | ||||||||
| Recursion Pharmaceuticals IncCommon Stock · shares +16% · price −12.1% | 2.0% | $215.9M | −$25.6M | ||||||||
| TeradyneCommon Stock · shares −3.8% · price −9.7% | 1.9% | $205.3M | −$22.0M | ||||||||
| Ark 21shares Bitcoin ETFETP · shares −8.0% · price +5.8% | 1.8% | $199.5M | +$11.0M | ||||||||
| Pagerduty IncCommon Stock · shares −8.0% · price −19.1% | 1.7% | $180.9M | −$42.7M | ||||||||
| Veracyte IncCommon Stock · shares −28% · price +57.1% | 1.5% | $167.5M | +$60.9M | ||||||||
| Beam Therapeutics IncCommon Stock · shares −14% · price +4.6% | 1.5% | $160.0M | +$7.0M | ||||||||
| Unity Software IncCommon Stock · shares −41% · price +39.1% | 1.4% | $150.8M | +$42.4M | ||||||||
| Pinterest IncCommon Stock · shares +0.9% · price −26.5% | 1.3% | $141.4M | −$50.7M | ||||||||
| The Trade DeskCommon Stock · shares −30% · price +12.3% | 1.3% | $138.8M | +$15.2M | ||||||||
| Tempus AICommon Stock · shares +355% · price +61.7% | 1.2% | $134.6M | +$11.3M | ||||||||
| Total · 194 positions | 100% | $10.93B | +$744.9M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2024 to Q3 2024: 175 stocks held throughout, up $744.9M (+7.7%).
- Tesla+$292.5M+32%
- Roku Inc+$165.3M+25%
- Palantir+$130.8M+47%
- Roblox+$83.5M+19%
- Shopify Inc+$65.8M+21%
- Pagerduty Inc−$42.7M−19%
- Pinterest Inc−$50.7M−27%
- Crispr Therapeutics Ag−$52.7M−13%
- Moderna Inc−$54.7M−44%
- Coinbase−$142.8M−20%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $15.40B+20% | SEC ↗ |
| Q1 2026 | May 12, 2026 | $12.86B−15% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $15.07B−10% | SEC ↗ |
| Q3 2025 | Nov 12, 2025 | $16.80B+23% | SEC ↗ |
| Q2 2025 | Jul 30, 2025 | $13.64B+37% | SEC ↗ |
| Q1 2025 | May 7, 2025 | $9.99B−17% | SEC ↗ |
| Q4 2024 | Feb 4, 2025 | $12.01B+10% | SEC ↗ |
| Q3 2024 | Oct 31, 2024 | $10.93B−3% | SEC ↗ |
| Q2 2024 | Jul 26, 2024 | $11.27B−22% | SEC ↗ |
| Q1 2024 | Apr 18, 2024 | $14.44B−14% | SEC ↗ |
| Q4 2023 | Jan 17, 2024 | $16.89B+29% | SEC ↗ |
| Q3 2023 | Oct 18, 2023 | $13.07B−13% | SEC ↗ |
| Q2 2023 | Jul 10, 2023 | $15.10B+4% | SEC ↗ |
| Q1 2023 | Apr 17, 2023 | $14.55B+26% | SEC ↗ |
| Q4 2022 | Jan 24, 2023 | $11.54B−20% | SEC ↗ |
| Q3 2022 | Oct 17, 2022 | $14.35B−15% | SEC ↗ |
| Q2 2022 | Jul 11, 2022 | $16.91B−29% | SEC ↗ |
| Q1 2022 | Apr 18, 2022 | $23.96B−28% | SEC ↗ |
| Q4 2021 | Jan 28, 2022 | $33.08B−21% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $41.64B−23% | SEC ↗ |
| Q2 2021 | Aug 5, 2021 | $53.74B+7% | SEC ↗ |
| Q1 2021 | May 13, 2021 | $50.34B+34% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $37.59B+123% | SEC ↗ |
| Q3 2020 | Oct 30, 2020 | $16.86B+81% | SEC ↗ |
| Q2 2020 | Aug 11, 2020 | $9.30B+132% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $4.01B+1% | SEC ↗ |
| Q4 2019 | Jan 31, 2020 | $3.96B−13% | SEC ↗ |
| Q3 2019 | Nov 12, 2019 | $4.58B+15% | SEC ↗ |
| Q2 2019 | Jul 30, 2019 | $3.97B+13% | SEC ↗ |
| Q1 2019 | May 13, 2019 | $3.50B+42% | SEC ↗ |
| Q4 2018 | Feb 11, 2019 (amended) | $2.46B−26% | SEC ↗ |
| Q3 2018 | Nov 7, 2018 | $3.31B+21% | SEC ↗ |
| Q2 2018 | Aug 7, 2018 | $2.73B+36% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $2.01B+60% | SEC ↗ |
| Q4 2017 | Feb 12, 2018 | $1.26B+53% | SEC ↗ |
| Q3 2017 | Nov 9, 2017 | $819.3M+60% | SEC ↗ |
| Q2 2017 | Aug 11, 2017 | $513.6M+48% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $346.9M+26% | SEC ↗ |
| Q4 2016 | Feb 13, 2017 | $274.9M | SEC ↗ |